Cite Filings / SYRE / 0001144204-17-062996
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Spyre Therapeutics, Inc. · Filed 2017-12-08 · Acc 0001144204-17-062996

Documents 1

  • SC 13G Amended Statement of Ownership , tv481066_sc13g.htm

Around this filing

  • 2018-02-13 SC 13G Amended Statement of Ownership
  • 2017-12-08 SC 13G Amended Statement of Ownership
  • 2017-12-08 4 Interim CEO bought 8,288 shares at an average $4.96 ($41,078)
  • 2017-12-05 4 Chief Financial Officer and VP bought 25,959 shares at an average $4.48 ($116,223)
  • 2017-12-05 4 Options or other derivatives
  • 2017-12-05 4 Director bought 17,121 shares at an average $4.86 ($83,177)
  • 2017-02-14 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tv481066_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…